Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $25.9 Million - $35.7 Million
-59,613 Reduced 52.81%
53,260 $28.6 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $27.5 Million - $36.7 Million
78,279 Added 226.28%
112,873 $52.9 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $10.7 Million - $12.6 Million
34,594 New
34,594 $11.9 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $7.96 Million - $9.89 Million
-33,903 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $1.24 Million - $1.54 Million
5,532 Added 19.5%
33,903 $9.36 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $6.29 Million - $7.74 Million
28,371 New
28,371 $6.55 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $1.14 Million - $1.48 Million
-6,963 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $15.6 Million - $20.6 Million
-119,262 Reduced 94.48%
6,963 $1.18 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $13.7 Million - $15.8 Million
93,421 Added 284.79%
126,225 $18.7 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $2.06 Million - $2.48 Million
-15,112 Reduced 31.54%
32,804 $5.38 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $3.04 Million - $3.31 Million
28,505 Added 146.85%
47,916 $5.36 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $6.64 Million - $8.3 Million
-77,348 Reduced 79.94%
19,411 $0
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $858,967 - $985,827
-11,347 Reduced 10.5%
96,759 $0
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $8.86 Million - $9.5 Million
108,106
108,106 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.